Sign Up for a Free Account
  • Updated 09.16.2020
  • Released 12.16.1998
  • Expires For CME 09.16.2023

Lamotrigine

Introduction

Historical note and terminology

The era of antiepileptic drugs started with the introduction of bromides in 1857. It was followed by the discovery of the anticonvulsant effect of barbiturates in 1912 and the introduction of hydantoins in 1916. Carbamazepine was introduced into clinical practice as an antiepileptic drug in 1963. Carbamazepine as well as lamotrigine blocks the repetitive firing of neurons by blocking sodium channels. Unrelated to any previous antiepileptic drug, lamotrigine reduces presynaptic excitatory amino acid release. Like most other antiepileptic drugs, the discovery of lamotrigine was serendipitous. Its discovery was based on the suggestion that the antiepileptic effect of phenytoin and phenobarbital is due to the disturbances of folate metabolism caused by these drugs (32). This led to an investigation of several folate antagonists in animal models, including phenyltriazines with strong antiepileptic action, even though the antifolate action was mild. Lamotrigine was developed from this category of compounds for treatment of partial seizures in 1995. It is approved worldwide.

This is an article preview.
Start a Free Account
to access the full version.

  • Nearly 3,000 illustrations, 
including video clips of 
neurologic disorders.

  • Every article is reviewed by our esteemed Editorial Board for accuracy and currency.

  • Full spectrum of 
neurology in 1,200 
comprehensive articles.

Questions or Comment?

MedLink, LLC

10393 San Diego Mission Rd, Suite 120

San Diego, CA 92108-2134

Toll Free (U.S. + Canada): 800-452-2400

US Number: +1-619-640-4660

Support: service@medlink.com

Editor: editor@medlink.com